ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Basal Insulin (Long-Acting Insulin) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-26I8164
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Basal Insulin Long Acting Insulin Market Insights Forecast to 2028
BUY CHAPTERS

Global Basal Insulin (Long-Acting Insulin) Market Research Report 2025

Code: QYRE-Auto-26I8164
Report
July 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Sanofi Aventis
Eli Lilly
Biocon Ltd.
Julphar
Exir
Sedico
WOCKHARDT

Basal Insulin (Long-Acting Insulin) Market

The global market for Basal Insulin (Long-Acting Insulin) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Long-acting insulins are also called basal or background insulins. The role of basal insulin, also known as background insulin, is to keep blood glucose levels at consistent levels during periods of fasting. When fasting , the body steadily releases glucose into the blood to our cells supplied with energy.
North American market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Basal Insulin (Long-Acting Insulin) include Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico, Wockhardt, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Basal Insulin (Long-Acting Insulin), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Basal Insulin (Long-Acting Insulin).
The Basal Insulin (Long-Acting Insulin) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Basal Insulin (Long-Acting Insulin) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Basal Insulin (Long-Acting Insulin) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Basal Insulin (Long-Acting Insulin) Market Report

Report Metric Details
Report Name Basal Insulin (Long-Acting Insulin) Market
Segment by Type
  • Lantus
  • Levemir
  • Tresiba
  • Toujeo
  • Basaglar
  • Biosimilar Glargines
Segment by Application
  • Type 1 Diabetes
  • Type 2 Diabetes
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico, Wockhardt
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Basal Insulin (Long-Acting Insulin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Basal Insulin (Long-Acting Insulin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Basal Insulin (Long-Acting Insulin) Market report?

Ans: The main players in the Basal Insulin (Long-Acting Insulin) Market are Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico, Wockhardt

What are the Application segmentation covered in the Basal Insulin (Long-Acting Insulin) Market report?

Ans: The Applications covered in the Basal Insulin (Long-Acting Insulin) Market report are Type 1 Diabetes, Type 2 Diabetes

What are the Type segmentation covered in the Basal Insulin (Long-Acting Insulin) Market report?

Ans: The Types covered in the Basal Insulin (Long-Acting Insulin) Market report are Lantus, Levemir, Tresiba, Toujeo, Basaglar, Biosimilar Glargines

1 Basal Insulin (Long-Acting Insulin) Market Overview
1.1 Product Definition
1.2 Basal Insulin (Long-Acting Insulin) by Type
1.2.1 Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lantus
1.2.3 Levemir
1.2.4 Tresiba
1.2.5 Toujeo
1.2.6 Basaglar
1.2.7 Biosimilar Glargines
1.3 Basal Insulin (Long-Acting Insulin) by Application
1.3.1 Global Basal Insulin (Long-Acting Insulin) Market Value by Application (2024 VS 2031)
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Basal Insulin (Long-Acting Insulin) Market Size Estimates and Forecasts
1.4.1 Global Basal Insulin (Long-Acting Insulin) Revenue 2020-2031
1.4.2 Global Basal Insulin (Long-Acting Insulin) Sales 2020-2031
1.4.3 Global Basal Insulin (Long-Acting Insulin) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Basal Insulin (Long-Acting Insulin) Market Competition by Manufacturers
2.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Basal Insulin (Long-Acting Insulin), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Product Type & Application
2.7 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Date of Enter into This Industry
2.8 Global Basal Insulin (Long-Acting Insulin) Market Competitive Situation and Trends
2.8.1 Global Basal Insulin (Long-Acting Insulin) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Basal Insulin (Long-Acting Insulin) Players Market Share by Revenue
2.8.3 Global Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Basal Insulin (Long-Acting Insulin) Market Scenario by Region
3.1 Global Basal Insulin (Long-Acting Insulin) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2020-2031
3.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2020-2025
3.2.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2026-2031
3.3 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2020-2031
3.3.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2020-2025
3.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2026-2031
3.4 North America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.4.1 North America Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.4.3 North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.5.1 Europe Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.5.3 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Region
3.6.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2020-2031)
3.6.3 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.7.1 Latin America Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.7.3 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.8.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2020-2031)
4.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2020-2025)
4.1.2 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2026-2031)
4.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2020-2031)
4.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2020-2031)
4.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2020-2025)
4.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2026-2031)
4.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2020-2031)
4.3 Global Basal Insulin (Long-Acting Insulin) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2020-2031)
5.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2020-2025)
5.1.2 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2026-2031)
5.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2020-2031)
5.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2020-2031)
5.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2020-2025)
5.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2026-2031)
5.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2020-2031)
5.3 Global Basal Insulin (Long-Acting Insulin) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi Aventis
6.2.1 Sanofi Aventis Company Information
6.2.2 Sanofi Aventis Description and Business Overview
6.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolio
6.2.5 Sanofi Aventis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Biocon
6.4.1 Biocon Company Information
6.4.2 Biocon Description and Business Overview
6.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biocon Basal Insulin (Long-Acting Insulin) Product Portfolio
6.4.5 Biocon Recent Developments/Updates
6.5 Julphar
6.5.1 Julphar Company Information
6.5.2 Julphar Description and Business Overview
6.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Julphar Basal Insulin (Long-Acting Insulin) Product Portfolio
6.5.5 Julphar Recent Developments/Updates
6.6 Exir
6.6.1 Exir Company Information
6.6.2 Exir Description and Business Overview
6.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Exir Basal Insulin (Long-Acting Insulin) Product Portfolio
6.6.5 Exir Recent Developments/Updates
6.7 Sedico
6.7.1 Sedico Company Information
6.7.2 Sedico Description and Business Overview
6.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sedico Basal Insulin (Long-Acting Insulin) Product Portfolio
6.7.5 Sedico Recent Developments/Updates
6.8 Wockhardt
6.8.1 Wockhardt Company Information
6.8.2 Wockhardt Description and Business Overview
6.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolio
6.8.5 Wockhardt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Basal Insulin (Long-Acting Insulin) Industry Chain Analysis
7.2 Basal Insulin (Long-Acting Insulin) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Basal Insulin (Long-Acting Insulin) Production Mode & Process Analysis
7.4 Basal Insulin (Long-Acting Insulin) Sales and Marketing
7.4.1 Basal Insulin (Long-Acting Insulin) Sales Channels
7.4.2 Basal Insulin (Long-Acting Insulin) Distributors
7.5 Basal Insulin (Long-Acting Insulin) Customer Analysis
8 Basal Insulin (Long-Acting Insulin) Market Dynamics
8.1 Basal Insulin (Long-Acting Insulin) Industry Trends
8.2 Basal Insulin (Long-Acting Insulin) Market Drivers
8.3 Basal Insulin (Long-Acting Insulin) Market Challenges
8.4 Basal Insulin (Long-Acting Insulin) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Sanofi Aventis
Eli Lilly
Biocon Ltd.
Julphar
Exir
Sedico
WOCKHARDT
List of Tables
 Table 1. Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Basal Insulin (Long-Acting Insulin) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Basal Insulin (Long-Acting Insulin) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Basal Insulin (Long-Acting Insulin), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Product Type & Application
 Table 12. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Basal Insulin (Long-Acting Insulin) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Basal Insulin (Long-Acting Insulin) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2020-2025)
 Table 19. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2026-2031)
 Table 21. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2020-2025)
 Table 23. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2026-2031)
 Table 25. North America Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2020-2025)
 Table 51. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2026-2031)
 Table 52. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2020-2025)
 Table 53. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2026-2031)
 Table 54. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2020-2025)
 Table 57. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2026-2031)
 Table 58. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2020-2025)
 Table 61. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2026-2031)
 Table 62. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2020-2025)
 Table 63. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2026-2031)
 Table 64. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2020-2025)
 Table 67. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2026-2031)
 Table 68. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Sanofi Aventis Company Information
 Table 76. Sanofi Aventis Description and Business Overview
 Table 77. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product
 Table 79. Sanofi Aventis Recent Developments/Updates
 Table 80. Eli Lilly Company Information
 Table 81. Eli Lilly Description and Business Overview
 Table 82. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Eli Lilly Basal Insulin (Long-Acting Insulin) Product
 Table 84. Eli Lilly Recent Developments/Updates
 Table 85. Biocon Company Information
 Table 86. Biocon Description and Business Overview
 Table 87. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Biocon Basal Insulin (Long-Acting Insulin) Product
 Table 89. Biocon Recent Developments/Updates
 Table 90. Julphar Company Information
 Table 91. Julphar Description and Business Overview
 Table 92. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Julphar Basal Insulin (Long-Acting Insulin) Product
 Table 94. Julphar Recent Developments/Updates
 Table 95. Exir Company Information
 Table 96. Exir Description and Business Overview
 Table 97. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Exir Basal Insulin (Long-Acting Insulin) Product
 Table 99. Exir Recent Developments/Updates
 Table 100. Sedico Company Information
 Table 101. Sedico Description and Business Overview
 Table 102. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sedico Basal Insulin (Long-Acting Insulin) Product
 Table 104. Sedico Recent Developments/Updates
 Table 105. Wockhardt Company Information
 Table 106. Wockhardt Description and Business Overview
 Table 107. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Wockhardt Basal Insulin (Long-Acting Insulin) Product
 Table 109. Wockhardt Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Basal Insulin (Long-Acting Insulin) Distributors List
 Table 113. Basal Insulin (Long-Acting Insulin) Customers List
 Table 114. Basal Insulin (Long-Acting Insulin) Market Trends
 Table 115. Basal Insulin (Long-Acting Insulin) Market Drivers
 Table 116. Basal Insulin (Long-Acting Insulin) Market Challenges
 Table 117. Basal Insulin (Long-Acting Insulin) Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Basal Insulin (Long-Acting Insulin)
 Figure 2. Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Basal Insulin (Long-Acting Insulin) Market Share by Type: 2024 & 2031
 Figure 4. Lantus Product Picture
 Figure 5. Levemir Product Picture
 Figure 6. Tresiba Product Picture
 Figure 7. Toujeo Product Picture
 Figure 8. Basaglar Product Picture
 Figure 9. Biosimilar Glargines Product Picture
 Figure 10. Global Basal Insulin (Long-Acting Insulin) Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Basal Insulin (Long-Acting Insulin) Market Share by Application: 2024 & 2031
 Figure 12. Type 1 Diabetes
 Figure 13. Type 2 Diabetes
 Figure 14. Global Basal Insulin (Long-Acting Insulin) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Basal Insulin (Long-Acting Insulin) Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Basal Insulin (Long-Acting Insulin) Sales (2020-2031) & (K Units)
 Figure 17. Global Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) & (2020-2031)
 Figure 18. Basal Insulin (Long-Acting Insulin) Report Years Considered
 Figure 19. Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers in 2024
 Figure 20. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Basal Insulin (Long-Acting Insulin) Players: Market Share by Revenue in Basal Insulin (Long-Acting Insulin) in 2024
 Figure 22. Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Basal Insulin (Long-Acting Insulin) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
 Figure 25. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
 Figure 26. United States Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
 Figure 29. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2020-2031)
 Figure 37. China Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Basal Insulin (Long-Acting Insulin) by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Basal Insulin (Long-Acting Insulin) by Type (2020-2031)
 Figure 58. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Basal Insulin (Long-Acting Insulin) by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Basal Insulin (Long-Acting Insulin) by Application (2020-2031)
 Figure 61. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2020-2031)
 Figure 62. Basal Insulin (Long-Acting Insulin) Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Long Acting Insulins Market Insights Forecast to 2030
Biosimilar Insulin Glargine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Drugs for Diabetes Market Research Report 2024
Global Insulin Glargine Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Low Protamine Zinc Insulin Market Research Report 2024
Global Long Acting Insulin Analogue Market Research Report 2025
Global Mealtime Insulin Market Research Report 2024
Global Short acting Insulin Market Research Report 2024
Global Rapid Acting Insulins Market Insights Forecast to 2030
Global Insulin Storage Devices Market Research Report 2024
Global Insulin Coolers Market Research Report 2024
Global Insulin Glargine and Lispro Market Research Report 2024
Global Premixed Insulin Analogs Market Research Report 2024
Global Insulin Preparation Market Research Report 2025
Global Insulin Raw Material Market Research Report 2025
Insulin Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin API Market Insights Forecast to 2030
Global Human Insulin Regular Market Research Report 2025
Global Premix Insulin Market Insights Forecast to 2030
Global Premixed Insulin Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions